Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Characterizing TDP-43 involvement in vascular dementia

Lookup NU author(s): Professor Raj KalariaORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2026 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.INTRODUCTION: Vascular dementia (VaD) is a major therapeutic challenge. Tar DNA-binding protein 43 (TDP-43), known for its role in neurodegeneration, may contribute to VaD pathogenesis under chronic cerebral hypoperfusion (CCH). This study investigates TDP-43 dysregulation in VaD. METHODS: TDP-43 and phosphorylated TDP-43 (pTDP-43) expression and localization were assessed in a VaD animal model, neuronal cells exposed to oxygen–glucose deprivation (OGD), and post mortem human brain tissues. RESULTS: Bilateral Common Carotid Artery Stenosis (BCAS)-induced CCH led to increased pTDP-43 and aberrant redistribution of both TDP-43 and pTDP-43. In vitro OGD triggered similar mislocalization. Post mortem VaD brains showed no TDP-43 abnormalities, while Alzheimer's and mixed dementia cases exhibited marked pathology. DISCUSSION: TDP-43 dysregulation appears early in VaD under hypoperfusive stress, distinguishing it from other dementia subtypes. These findings indicate that TDP‑43 may warrant further investigation as a potential early molecular feature of VaD. Highlights: Tar DNA-binding protein 43 (TDP-43) is dysregulated early in vascular dementia models. Hypoperfusion triggers TDP-43 mislocalization and phosphorylation. TDP-43 pathology is absent in late-stage human vascular dementia. TDP-43 is a transient, novel target for vascular cognitive impairment.


Publication metadata

Author(s): Fung M, Chai YL, Cheng Y-L, Tabassum N, Lim VJT, Kalaria RN, Jo D-G, Chen CP, Lai MKP, Arumugam TV

Publication type: Article

Publication status: Published

Journal: Alzheimer's and Dementia

Year: 2026

Volume: 22

Issue: 2

Print publication date: 01/02/2026

Online publication date: 14/02/2026

Acceptance date: 11/01/2026

Date deposited: 23/02/2026

ISSN (print): 1552-5260

ISSN (electronic): 1552-5279

Publisher: John Wiley and Sons Inc

URL: https://doi.org/10.1002/alz.71196

DOI: 10.1002/alz.71196


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
National Health and Medical Research Council of Australia, Grant/Award Number: 2019100
National Medical Research Council of Singapore, Grant/Award Number: MOH-001086-00

Share